col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


69 Results       Page 1

 [1] 
Elsevier: Contemporary Clinical Trials
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Mar―06 Design and conduct of a randomized controlled feeding trial in a residential setting with mitigation for COVID-19 Julia M.W. Wong, David S. Ludwig, David B. Allison, Navneet Baidwan, Lisa Bielak, Chia-Ying Chiu, Stephanie L. Dickinson, Lilian Golzarri-Arroyo, Steven B. Heymsfield, Lauren Holmes, Lisa T. Jansen, Donna Lesperance, Tapan Mehta, Megan Sandman, Sarah K. Steltz, William W. Wong, Shui Yu, Cara B. Ebbeling
2 [GO] 2023―Dec―12 Mitigation through on-site testing & education among formerly incarcerated individuals against Covid-19 - The MOSAIC study: Design and rationale Maxwell Ackerman, Connor S. Holmes, Jordy Rojas Antigua, Lindsey R. Riback, Chenshu Zhang, Josephine G. Walker, Peter Vickerman, Ann Travers, Micaela Linder, Ronald Day, Aaron D. Fox, Chinazo O. Cunningham, Matthew J. Akiyama
3 [GO] 2023―Dec―10 Studying the impact of COVID-19 mitigation policies on childhood obesity, health behaviors, and disparities in an observational cohort: Protocol for the COVID-19 Family Study Nan Dou, Rachel Deitch, Alysse J. Kowalski, Ann Pulling Kuhn, Hannah Lane, Elizabeth A. Parker, Yan Wang, Zafar Zafari, Maureen M. Black, Erin R. Hager
4 [GO] 2023―Dec―03 Engaging staff to improve COVID-19 vaccination response at long-term care facilities (ENSPIRE): A cluster randomized trial of co-designed, tailored vaccine promotion materials Clarissa Hsu, Brian D. Williamson, Marla Becker, Breana Berry, Andrea J. Cook, Alphonse Derus, Camilo Estrada, Margaret Gacuiri, Ahoua Kone, Courtney McCracken, Bennett McDonald, Annalisa V. Piccorelli, Kirsten Senturia, Jaclyn Volney, Kanetha B. Wilson, Beverly B. Green
5 [GO] 2023―Aug―30 Developing and testing a COVID-19 vaccination acceptance intervention: A pragmatic trial comparing vaccine acceptance intervention vs usual care - Rationale, methods, and implementation Jeffrey M. Pyne, Karen H. Seal, Jennifer K. Manuel, Beth DeRonne, Karen Anderson Oliver, Dan Bertenthal, Denise Esserman, Natalie Purcell, Beth Ann Petrakis, A. Rani Elwy
6 [GO] 2023―Aug―30 Developing resilient clinical trials: Lessons learned from rolling out the get back to healthy trial during a pandemic Emma K. Ho, Manuela L. Ferreira, Paul Hodges, Mark Halliday, Katherine Maka, Dragana Ceprnja, Matthew Jennings, Anita B. Amorim, Melissa T. Baysari, Paulo H. Ferreira
7 [GO] 2023―Jul―16 Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics Joan Buenconsejo, Ran Liao, Junjing Lin, Pritibha Singh, Freda Cooner, Samiran Ghosh, Margaret Gamalo, Estelle Russek-Cohen, Névine Zariffa
8 [GO] 2023―Jun―22 Recruiting experiences of NIH-funded principal investigators for community-based health behavior interventions during the COVID-19 pandemic Rebecca A. Seguin-Fowler, Margaret Demment, Sara C. Folta, Meredith Graham, Karla Hanson, Jay E. Maddock, Megan S. Patterson
9 [GO] 2023―Jun―09 Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study Claire Fougerou-Leurent, Christelle Delmas, Juliette Saillard, Marina Dumousseaux, Assia Ferrane, Noémie Mercier, Vida Terzic, Soizic Le Mestre, Aline Dechanet, Drifa Belhadi, Annabelle Metois, Charles Burdet, France Mentre, Marion Noret, Alpha Diallo, Ventzislava Petrov-Sanchez, Sandrine Couffin-Cadiergues, Maya Hites, Florence Ader, Hélène Esperou
10 [GO] 2023―May―29 Implementing a randomised controlled trial through community pharmacies to support people living with severe and persistent mental illness: Lessons learnt during the COVID-19 pandemic Claire L. O'Reilly, Sara S. McMillan, Sarira El-Den, Jack C. Collins, Jie Hu, Ricki Ng, Victoria Stewart, Lily Pham, Fleur Webb, Helena Roennfeldt, Rebecca Segrott, Hannah Loller, Amanda J. Wheeler
11 [GO] 2023―Apr―19 Chronic obstructive pulmonary disease access and adherence to pulmonary rehabilitation intervention (CAPRI): Protocol for a randomized controlled trial and adaptations during the COVID-19 pandemic Patricia M. Bamonti, Stephanie A. Robinson, Elizabeth Finer, Reema Kadri, David Gagnon, Caroline R. Richardson, Marilyn L. Moy
12 [GO] 2023―Apr―15 The effect of the COVID-19 pandemic on US Food and Drug Administration funded clinical trials and natural history studies for rare diseases Kathleen L. Miller, Katherine I. Miller Needleman
13 [GO] 2023―Apr―07 The impact of COVID-19 on a large pragmatic clinical trial embedded in primary care Sarah M. Leatherman, Cynthia Hau, Alison Klint, Peter A. Glassman, Addison A. Taylor, Ryan E. Ferguson, William C. Cushman, Areef Ishani
14 [GO] 2023―Jan―16 A rank-based approach to design and analysis of pretest-posttest randomized trials, with application to COVID-19 ordinal scale data Guangyong Zou, Emma J. Smith, Lily Zou, Shi-Fang Qiu, Di Shu
15 [GO] 2023―Jan―09 Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Erika Holmberg, Sara Schiller, Colleen Shannon, Mary Brophy, Paul Monach, Sarah Leatherman, Westyn Branch-Elliman
16 [GO] 2022―Dec―17 Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial Julie H. Levison, David Krane, Karen Donelan, Kelly Aschbrenner, Hao D. Trieu, Cindy Chau, Anna Wilson, Nicolas M. Oreskovic, Kelly Irwin, Lisa I. Iezzoni, Haiyi Xie, Ronita Samuels, Paula Silverman, Joey Batson, Ahmed Fathi, Stefanie Gamse, Sibyl Holland, Jessica Wolfe, Kim Shellenberger, Elizabeth Cella, Bruce Bird, Brian G. Skotko, Stephen Bartels
17 [GO] 2022―Dec―05 How much did it cost to develop and implement an eHealth intervention for a minority children population that overlapped with the COVID-19 pandemic Alexandra Monashefsky, Dar Alon, Tom Baranowski, Tiago V. Barreira, Kelly A. Chiu, Amy Fleischman, Melanie C. Green, Shirley Huang, Ronald C. Samuels, Caio Victor Sousa, Debbe Thompson, Amy S. Lu
18 [GO] 2022―Nov―25 Designing a virtual mental health consultation program to support and strengthen childcare centers impacted by COVID-19: A randomized controlled trial protocol Ruby Natale, Yaray Agosto, Rebecca J. Bulotsky-Shearer, Sara M. St. George, Jason Jent
19 [GO] 2022―Nov―08 Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A review Daniel B. Chastain, Vishwa S. Patel, Alexandria M. Jefferson, Sharmon P. Osae, Joeanna S. Chastain, Andrés F. Henao-Martínez, Carlos Franco-Paredes, Henry N. Young
20 [GO] 2022―Nov―05 Reaching high-risk Black adults for diabetes prevention programming during a pandemic: The design of Fit & Faithful a randomized controlled community trial Lovoria B. Williams, Debra K. Moser, Alison Gustafson, Teresa M. Waters, Mary Kay Rayens, Erika R. Karle, Andrea M. Kriska
21 [GO] 2022―Sep―22 The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort study Sarah D. Tait, Chana A. Sacks, Michael Dougan, Keri Sullivan, Alexander C. Tsai, Thomas H. McCoy, Crystal M. North
22 [GO] 2022―Aug―21 Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California Vivian Levy, Ruth Yanes Bengoa, Priscilla Padilla Romero, Jenna Bollyky, Upinder Singh
23 [GO] 2022―Jun―11 The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, Derek C. Angus, Anna Nakayama, Rachel L. Zapf, Paula L. Kip, Christopher W. Seymour, David T. Huang
24 [GO] 2022―Jun―09 A pragmatic randomized trial of home-based testing for COVID-19 in rural Native American and Latino communities: Protocol for the “Protecting our Communities” study Matthew J. Thompson, Paul K. Drain, Charlie E. Gregor, Laurie A. Hassell, Linda K. Ko, Victoria Lyon, Selena Ahmed, Sonia Bishop, Virgil Dupuis, Lorenzo Garza, Allison A. Lambert, Carly Rowe, Teresa Warne, Eliza Webber, Wendy Westbroek, Alexandra K. Adams
25 [GO] 2022―May―26 Clinic navigation and home visits to improve asthma care in low income adults with poorly controlled asthma: Before and during the pandemic Andrea J. Apter, Tyra Bryant-Stephens, Xiaoyan Han, Hami Park, Anna Morgan, Heather Klusaritz, Zuleyha Cidav, Audreesh Banerjee, A. Russell Localio, Knashawn H. Morales
26 [GO] 2022―May―07 Implementing expanded COVID-19 testing in Massachusetts community health centers through community partnerships: Protocol for an interrupted time series and stepped wedge study design Gina Kruse, Leslie Pelton-Cairns, Elsie Taveras, Susan Dargon-Hart, Daniel A. Gundersen, Rebekka M. Lee, Barbara E. Bierer, Erica Lawlor, Regina LaRocque, Julia L. Marcus, Madeline E. Davies, Karen Emmons
27 [GO] 2022―Apr―22 Protecting the mental and physical well-being of frontline health care workers during COVID-19: Study protocol of a cluster randomized controlled trial Lu Dong, Lisa S. Meredith, Carrie Farmer, Sangeeta Ahluwalia, Peggy Chen, Kathryn Bouskill, Bing Han, Nabeel Qureshi, Sarah Dalton, Patricia Watson, Paula P. Schnurr, Katy Davis, Jonathan N. Tobin, Andrea Cassells, Courtney Gidengil
28 [GO] 2022―Apr―20 One committee to review them all: A single, multi-disciplinary COVID-19 research committee Jocelyn Migliacci, Ann Rodavitch, Gregory Riely, Paul Sabbatini, Collette Houston, Sara Hanley
29 [GO] 2022―Apr―06 Handling death as an Intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials Hong Li, Kevin J. Gleason, Yiran Hu, Sandra S. Lovell, Saurabh Mukhopadhyay, Li Wang, Bidan Huang
30 [GO] 2022―Apr―04 The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design Konrad Rejdak, Piotr Fiedor, Robert Bonek, Aleksander Goch, Agnieszka Gala-Błądzińska, Waldemar Chełstowski, Jacek Łukasiak, Sławomir Kiciak, Piotr Dąbrowski, Mateusz Dec, Zbigniew J. Król, Ewa Papuć, Adriana Zasybska, Agnieszka Segiet, Paweł Grieb
31 [GO] 2022―Mar―21 Impact of COVID-19 pandemic on oncology clinical trial design, data collection and analysis Rui (Sammi) Tang, Jian Zhu, Tai-Tsang Chen, Fang Liu, Xun Jiang, Bo Huang, J. Jack Lee, Robert A. Beckman
32 [GO] 2022―Feb―16 COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic Kristina Larson, Ida Sim, Megan von Isenburg, Marcia Levenstein, Frank Rockhold, Stan Neumann, Catherine D'Arcy, Elizabeth Graham, David Zuckerman, Rebecca Li
33 [GO] 2022―Feb―08 COVID-19 vaccines: Considering sex differences in efficacy and safety Adelaide Jensen, Masha Stromme, Shayda Moyassari, Antonella Santuccione Chadha, Maria Carmela Tartaglia, Cassandra Szoeke, Maria Teresa Ferretti
34 [GO] 2022―Jan―16 The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis Mary C. Greenough, Nicholas B. Sajjadi, Brayden Rucker, Matt Vassar, Micah Hartwell
35 [GO] 2021―Dec―09 Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyer, Tina Khadem, William Garrard, Kevin Collins, Alan Wells, Robert D. Bart, Kelsey Linstrum, Stephanie K. Montgomery, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Christopher W. Seymour, Donald M. Yealy, David T. Huang, Derek C. Angus
36 [GO] 2021―Nov―23 Modified Application of Cardiac Rehabilitation in Older Adults (MACRO) Trial: Protocol changes in a pragmatic multi-site randomized controlled trial in response to the COVID-19 pandemic Daniel E. Forman, Susan B. Racette, Pamela E. Toto, Linda R. Peterson, Nancy W. Glynn, Jennifer Pruskowski, Thomas Byard, Amanda Delligatti, Rebecca Lolley, Vinaya Mulkareddy, Kelly Allsup, Subashan Perera, Eric J. Lenze, Michael W. Rich
37 [GO] 2021―Nov―15 Implementation of platform trials in the COVID-19 pandemic: A rapid review Alyssa M. Vanderbeek, Judith M. Bliss, Zhulin Yin, Christina Yap
38 [GO] 2021―Nov―12 Assessing the impact of the COVID-19 pandemic on pragmatic clinical trial participants Brian C. Coleman, Natalie Purcell, Mary Geda, Stephen L. Luther, Peter Peduzzi, Robert D. Kerns, Karen H. Seal, Diana J. Burgess, Marc I. Rosen, John Sellinger, Stacie A. Salsbury, Hannah Gelman, Cynthia A. Brandt, Robert R. Edwards
39 [GO] 2021―Oct―29 Developing a virtual assessment protocol for the AMPLIFI Randomized Controlled Trial due to COVID-19: From assessing participants' preference to preparing the team Maria Pisu, Iman Omairi, Teri Hoenemeyer, Karina I. Halilova, Yu-Mei M. Schoenberger, Laura Q. Rogers, Kelly M. Kenzik, Robert A. Oster, Nataliya V. Ivankova, Dori Pekmezi, Kevin Fontaine, Wendy Demark-Wahnefried, Michelle Y. Martin
40 [GO] 2021―Oct―14 Japanese project for telepsychiatry evaluation during COVID-19: Treatment comparison trial (J-PROTECT): Rationale, design, and methodology Taishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, Masaru Mimura, Takashi Nakamae, Yoshinari Abe, Tetsufumi Kanazawa, Yasuo Kawabata, Hiroaki Tomita, Koichi Abe, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Yoshinori Watanabe, Toru Amagai, Kei Sakuma, Hisashi Kida, Michitaka Funayama, Hiroshi Kimura, Aiko Sato, Shuichiro Fujiwara, Kiichiro Nagao, Naoya Sugiyama, Maki Takamiya, Hideyuki Kodama, Takaharu Azekawa
41 [GO] 2021―Oct―02 The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: A randomized controlled trial to increase COVID-19 testing in underserved populations Cedric H. Bien-Gund, Jesal Shah, Joshua I. Ho, Alisa Stephens-Shields, Kathleen Shea, Jessica Fishman, Harsha Thirumurthy, Trisha Acri, Karen Dugosh, Robert Gross
42 [GO] 2021―Sep―28 Modified Reference Based Imputation and Tipping Point Analysis In the Presence of Missing Data Due to COVID-19 Man Jin, Ran Liu, Weining Robieson
43 [GO] 2021―Aug―28 Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial Tayyab Shah, Marianne McCarthy, Irem Nasir, Herb Archer, Elio Ragheb, Jonathan Kluger, Nitu Kashyap, Carlos Paredes, Prashant Patel, Jing Lu, Prakash Kandel, Christopher Song, Mustafa Khan, Faheem Ul Haq, Rami Ahmad, Christopher Howes, Brian Cambi, Gilead Lancaster, Michael Cleman, Charles De La Cruz, Helen Parise, Alexandra Lansky
44 [GO] 2021―Aug―13 Rationale and design of the prone position and respiratory outcomes in non-intubated COVID-19 patients: The “PRONE” study Eugene Friedman, John Franzone, Emily Ray Ko, Kristin Corey, Jason Mock, Naseem Alavian, Adam Schwartz, M. Bradley Drummond, Tomeka Suber, Kelsey Linstrum, William Bain, Saramaria Afanador Castiblanco, Martin Zak, Sandra Zaeh, Ishaan Gupta, Mahendra Damarla, Naresh M. Punjabi
45 [GO] 2021―Jul―16 The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial Bryan Bunning, Haley Hedlin, Natasha Purington, Vandana Sundaram, Kristopher Kapphahn, Yingjie Weng, Kristen Cunanan, Yvonne Maldonado, Upinder Singh, Chaitan Khosla, Ruth O'Hara, Mark Nicolls, Eric Springman, Julie Parsonnet, Angela Rogers, Joseph Levitt, Manisha Desai
46 [GO] 2021―Jul―02 An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic K. Shin Park, Jennifer L. Etnier
47 [GO] 2021―May―29 The link between vitamin D and COVID-19 Daniel M.O. Campos, Edilson D. Silva Jr, Umberto L. Fulco, Jonas I.N. Oliveira
48 [GO] 2021―May―29 Response to the letter to the editor: “The link between Vitamin D and COVID-19 Davaasambuu Ganmaa, Rui Wang, Walter C. Willett, JoAnn E. Manson
49 [GO] 2021―Apr―20 Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic Seol Ju E. Moon, Annette DeVito Dabbs, Andrea L. Hergendroeder, Melissa L. Vendetti, Kristen B. Jones, Bryan M. Willey, Matthew R. Morrell, Christopher C. Imes
50 [GO] 2021―Mar―26 Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic Most Alina Afroz, Grant Schwarber, Mohammad Alfrad Nobel Bhuiyan
51 [GO] 2021―Mar―12 A multi-center trial of exercise and testosterone therapy in women after hip fracture: Design, methods and impact of the COVID-19 pandemic Ellen F. Binder, Jesse C. Christensen, Jennifer Stevens-Lapsley, Jenna Bartley, Sarah D. Berry, Adrian S. Dobs, Richard H. Fortinsky, Kerry L. Hildreth, Douglas P. Kiel, George A. Kuchel, Robin L. Marcus, Christine M. McDonough, Denise Orwig, David R. Sinacore, Robert S. Schwartz, Elena Volpe, Jay Magaziner, Kenneth B. Schechtman
52 [GO] 2021―Feb―23 RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19 Veeral Ajmera, Wesley K. Thompson, Davey M. Smith, Atul Malhotra, Ravindra L. Mehta, Vaishal Tolia, Jeffrey Yin, Krishna Sriram, Paul A. Insel, Summer Collier, Lisa Richards, Rohit Loomba
53 [GO] 2021―Jan―27 Clinical trial preparations for the next pandemic Jay Herson
54 [GO] 2021―Jan―10 Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Ahmad Al-Abdouh, Anas Bizanti, Mahmoud Barbarawi, Ahmad Jabri, Ashish Kumar, Oluwaseun E. Fashanu, Safi U. Khan, Di Zhao, Annukka A.R. Antar, Erin D. Michos
55 [GO] 2020―Dec―18 Guest Editors'-in-Chief Note to COVID-19 Special Issue. Zheng Su, Sue-Jane Wang
56 [GO] 2020―Dec―04 Reporting and design of randomized controlled trials for COVID-19: A systematic review Alison Dillman, Jay J.H. Park, Michael J. Zoratti, Noor-E Zannat, Zelyn Lee, Louis Dron, Grace Hsu, Gerald Smith, Sahand Khakabimamaghani, Ofir Harari, Kristian Thorlund, Edward J. Mills
57 [GO] 2020―Nov―11 Causal inference methods for small non-randomized studies: Methods and an application in COVID-19 Sarah Friedrich, Tim Friede
58 [GO] 2020―Nov―10 Reacting to crises: The COVID-19 impact on biostatistics/epidemiology Robert T. O'Neill
59 [GO] 2020―Nov―02 Modifications to communities for healthy Living trial design resulting from COVID-19 Kirsten K. Davison, Sebastien Hanuese
60 [GO] 2020―Oct―23 Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country Geert Molenberghs, Marc Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, Geert Verbeke, Pierre Van Damme, Herman Goossens, Thomas Neyens, Sereina Herzog, Heidi Theeten, Koen Pepermans, Ariel Alonso Abad, Ingrid Van Keilegom, Niko Speybroeck, Catherine Legrand, Stefanie De Buyser, Frank Hulstaert
61 [GO] 2020―Oct―10 The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design Rui Wang, Victor DeGruttola, Quanhong Lei, Kenneth H. Mayer, Susan Redline, Aditi Hazra, Samia Mora, Walter C. Willett, Davaasambuu Ganmaa, JoAnn E. Manson
62 [GO] 2020―Oct―06 TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Facciolongo, Fiorentino Fraganza, AnnaMaria Marata, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Roberto Parrella, Patrizia Popoli, Gerardo Botti, Laura Arenare, Paolo Chiodini, Ciro Gallo, Carlo Salvarani, Francesco Perrone
63 [GO] 2020―Sep―20 Data monitoring committees for clinical trials evaluating treatments of COVID-19 Tobias Mütze, Tim Friede
64 [GO] 2020―Sep―20 COVID-19 hits a trial: Arguments against hastily deviating from the plan Anika Großhennig, Armin Koch
65 [GO] 2020―Sep―15 Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model Tianjian Zhou, Yuan Ji
66 [GO] 2020―Sep―12 Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19 Zachary R. McCaw, Lu Tian, Kevin N. Sheth, Wan-Ting Hsu, W. Taylor Kimberly, Lee-Jen Wei
67 [GO] 2020―Aug―08 Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out? Halah Ibrahim, Ashraf M. Kamour, Thana Harhara, Waqar H. Gaba, Satish C. Nair
68 [GO] 2020―Aug―06 The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan Hsiao-Hui Tsou, Yu-Chieh Cheng, Hsiang-Yu Yuan, Ya-Ting Hsu, Hsiao-Yu Wu, Fang-Jing Lee, Chao A. Hsiung, Wei J. Chen, Huey-Kang Sytwu, Shiow-Ing Wu, Shu-Man Shih, Tzai-Hung Wen, Shu-Chen Kuo
69 [GO] 2020―Apr―06 Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? Hala T. Borno, Eric J. Small
 [1] 

69 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec